Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 76 +0.50 (+0.66%) Sep 1
At Loss
P/B:
8.16
Market Cap:
€ 6.71B ($ 7.78B)
Enterprise V:
€ 5.85B ($ 6.78B)
Volume:
23.00
Avg Vol (2M):
122.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts